
Lidorestat
CAS No. 245116-90-9
Lidorestat( —— )
Catalog No. M33408 CAS No. 245116-90-9
Lidorestat (IDD-676) is an aldose reductase inhibitor (IC50: 5 nM) with effective, selective and oral activity. Lidorestat improves nerve conduction and reduces the formation of cataracts.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 38 | Get Quote |
![]() ![]() |
10MG | 61 | Get Quote |
![]() ![]() |
25MG | 99 | Get Quote |
![]() ![]() |
50MG | 152 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLidorestat
-
NoteResearch use only, not for human use.
-
Brief DescriptionLidorestat (IDD-676) is an aldose reductase inhibitor (IC50: 5 nM) with effective, selective and oral activity. Lidorestat improves nerve conduction and reduces the formation of cataracts.
-
DescriptionLidorestat (IDD-676) is a potent, selective and orally active aldose reductase inhibitor with an IC50 of 5 nM. Lidorestat can be used for chronic diabetes complications. Lidorestat also improves nerve conduction and reduces cataract formation.
-
In VitroFrom in vitro experiments, Lidorestat has a reported IC50 against recombinant human aldose reductase (/h/-ALR2) of 5 μM. Against recombinant human aldehyde reductase (/h/-ALR1), Lidorestat has a reported IC50 of 27,000 μM, yielding a selectivity of /h/-ALR1//h/-ALR2 of 5400:1.
-
In VivoLidorestat (25 mg/kg/day; oral administration; twice daily; for 6 weeks; diabetic mice) treatment decreases fructose and reduces mortality in diabetic hAR-expressing mice. And Lidorestat does not affect weight.Animal Model:Diabeticlow-density lipoprotein (LDL) receptor-deficient [Ldlr(-/-)] mice Dosage:25 mg/kg/day Administration:Oral administration; twice daily; for 6 weeks Result: Diabetic hAR-expressing mice had decreased fructose and reduced mortality.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetReductase
-
RecptorReductase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number245116-90-9
-
Formula Weight376.35
-
Molecular FormulaC18H11F3N2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (132.86 mM; Ultrasonic (<60°C)
-
SMILESOC(=O)Cn1cc(Cc2nc3c(F)c(F)cc(F)c3s2)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Noh HL, et al. Regulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat. J Pharmacol Exp Ther. 2009 Feb;328(2):496-503.?
molnova catalog



related products
-
CH5138303
CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM.
-
Sulindac sulfone
Sulindac sulfone is a metabolite of the nonsteroidal anti-inflammatory drug sulindac. Sulindac sulfone is an inhibitor of aldose reductase (IC50 =367 nM).
-
MK 0434
MK 0434 is an orally active steroidal 5 alpha-reductase inhibitor.